PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-11-14

Date Title Company
14-Nov-2024 Acreage Reports Third Quarter 2024 Financial Results AccessWire
14-Nov-2024 Comment on Media Report AccessWire
14-Nov-2024 CaaMTech's Psychedelic Functional Unblinding Strategy Gets Regulatory Blessing AccessWire
14-Nov-2024 Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st AccessWire
14-Nov-2024 Comment on media report Evotec SE
14-Nov-2024 CaaMTech’s Psychedelic Functional Unblinding Strategy Gets Regulatory Blessing Newswire
14-Nov-2024 ADM Tronics Reports Second Quarter of Fiscal Year 2025 Results AccessWire
14-Nov-2024 Abivax presents third quarter 2024 key financial information ABIVAX
14-Nov-2024 Supporting Part-Time Employees Just Got Easier: A Non-Insurance Benefit You Can Implement Anytime AccessWire
14-Nov-2024 Michigan Psychological Care Launches New Psychiatry Services, No Waitlist, in Midland and Saint Johns, MI AccessWire
14-Nov-2024 AGFA HealthCare Expands the Enterprise Imaging Platform to Cardiology at Zuckerberg San Francisco General Hospital AccessWire
14-Nov-2024 pobl. welcomes Lindsey Heer as Partner, Talent Strategy, elevating expertise in Medical Communications and Life Sciences pobl.
14-Nov-2024 Sea Pharmaceuticals Advancing Oral Neurotherapeutics as Potential Medicines for Tinnitus, Epilepsy, and ALS in Collaboration with TCG GreenChem AccessWire
14-Nov-2024 Cloud Storage Security Launches Antimalware for Azure Blob AccessWire
14-Nov-2024 Glidewell Introduces Simply Natural(TM) Digital Dentures With Antimicrobial Properties AccessWire
14-Nov-2024 Aravax Establishes Pharmaceutical Development base on the Oxford Science Park with a Focus on Developing Manufacturing Capabilities in the UK Aravax
14-Nov-2024 Great Place To Work and Fortune Name Chiesi Group No. 23 in 2024 World’s Best Workplaces™ List Chiesi Group
14-Nov-2024 AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease AC Immune
14-Nov-2024 SEKISUI Completes £15.7 Million Expansion in cGMP Biopharma CDMO Capacity SEKISUI
14-Nov-2024 Terumo Blood and Cell Technologies Unlocks New Chapter of Localization in China to Facilitate Blood and Cell Treatment Options for Patients Terumo Blood and Cell Technologies